A new challenge for successful immunotherapy by tumors that are resistant to apoptosis: two complementary signals to overcome cross-resistance. [electronic resource]
Producer: 20030407Description: 145-74 p. digitalISSN:- 0065-230X
- Adjuvants, Immunologic -- pharmacology
- Animals
- Antineoplastic Agents -- pharmacology
- Apoptosis -- drug effects
- Caspases -- physiology
- Drug Design
- Drug Resistance, Neoplasm
- Humans
- Immunotherapy -- methods
- Mice
- Mice, SCID
- Mitochondria -- physiology
- Models, Biological
- Neoplasm Proteins -- physiology
- Neoplasms -- immunology
- Proto-Oncogene Proteins -- physiology
- Receptors, Tumor Necrosis Factor -- physiology
- T-Lymphocytes, Cytotoxic -- immunology
- Tumor Necrosis Factor-alpha -- pharmacology
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Review
There are no comments on this title.
Log in to your account to post a comment.